Loading...
Please wait, while we are loading the content...
Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose
| Content Provider | Scilit |
|---|---|
| Author | Griswold, Matthew K. Chai, Peter R. Krotulski, Alex J. Friscia, Melissa Chapman, Brittany Boyer, Edward W. Logan, Barry K. Babu, Kavita M. |
| Copyright Year | 2017 |
| Description | To compare user self-identification of nonpharmaceutical fentanyl exposure with confirmatory urine drug testing in emergency department (ED) patients presenting after heroin overdose. This was a cross-sectional study of adult ED patients who presented after a heroin overdose requiring naloxone administration. Participants provided verbal consent after which they were asked a series of questions regarding their knowledge, attitudes and beliefs toward heroin and non-pharmaceutical fentanyl. Participants also provided urine samples, which were analyzed using liquid chromatography coupled to quadrupole time-of-flight mass spectrometry to identify the presence of fentanyl, heroin metabolites, other clandestine opioids, common pharmaceuticals and drugs of abuse. Thirty participants were enrolled in the study period. Ten participants (33%) had never required naloxone for an overdose in the past, 20 participants (67%) reported recent abstinence, and 12 participants (40%) reported concomitant cocaine use. Naloxone was detected in all urine drug screens. Heroin or its metabolites were detected in almost all samples (93.3%), as were fentanyl (96.7%) and its metabolite, norfentanyl (93.3%). Acetylfentanyl was identified in nine samples (30%) while U-47700 was present in two samples (6.7%). Sixteen participants self-identified fentanyl in their heroin (sensitivity 55%); participants were inconsistent in their qualitative ability to identify fentanyl in heroin. Heroin users presenting to the ED after heroin overdose requiring naloxone are unable to accurately identify the presence of nonpharmaceutical fentanyl in heroin. Additionally, cutting edge drug testing methodologies identified fentanyl exposures in 96.7% of our patients, as well as unexpected clandestine opioids (like acetylfentanyl and U-47700). |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975225/pdf |
| Ending Page | 42 |
| Page Count | 6 |
| Starting Page | 37 |
| ISSN | 15563650 |
| e-ISSN | 15569519 |
| DOI | 10.1080/15563650.2017.1339889 |
| Journal | Clinical Toxicology |
| Issue Number | 1 |
| Volume Number | 56 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2018-01-02 |
| Access Restriction | Open |
| Subject Keyword | Substance Abuse Heroin Fentanyl Overdose Acetylfentanyl U-47700 Opioid Epidemic Drug Testing Time-of-flight |
| Content Type | Text |
| Resource Type | Article |
| Subject | Medicine Toxicology |
